Therapy Areas: Respiratory
Flagship Pioneering announces new agreements with ProFound Therapeutics and Quotient Therapeutics under GSK collaboration
21 November 2025 - Flagship Pioneering, a scientific innovation engine for transformative platforms and products, announced on Thursday that ProFound Therapeutics and Quotient Therapeutics have entere...
Nuvalent's zidesamtinib NDA filing accepted by US FDA
20 November 2025 - Clinical-stage biopharmaceutical company Nuvalent Inc (Nasdaq:NUVL) said on Wednesday that the US Food and Drug Administration (FDA) has accepted for filing its New Drug Application...
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
19 November 2025 - BioNet, a biotechnology company developing and manufacturing next generation vaccines including recombinant and mRNA vaccines, announced on Tuesday that it has received positive opi...
Probi launches new human and pet biotics ranges
19 November 2025 - Sweden-based biotics solutions company Probi, a subsidiary of German chemicals company Symrise AG (ETR: SY1), announced on Wednesday that it has expanded its portfolio with two new ...
European Commission approves Insmed's BRINSUPRI for the treatment of non-cystic fibrosis bronchiectasis
18 November 2025 - US-based biopharmaceutical company Insmed Incorporated (Nasdaq: INSM) said on Tuesday that the European Commission has approved BRINSUPRI (brensocatib 25mg tablets) for patients wit...
Pulmonary Fibrosis Foundation Launches New Five-Year Strategy: The PFF is ME
18 November 2025 - The Pulmonary Fibrosis Foundation (PFF) has introduced a comprehensive five-year strategic plan titled The PFF is ME, developed using the insights and lived experiences of more than...